IVTCOVID 19 Trident
Alternative Names: IVT-COVID19 TridentLatest Information Update: 09 Dec 2021
At a glance
- Originator Inventprise
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Research COVID 2019 infections
Most Recent Events
- 29 Nov 2021 IVTCOVID 19 Trident is available for licensing as of 29 Nov 2021. https://www.inventprise.com/?page_id=1938
- 29 Nov 2021 Inventprise has patent protection for technologies associated with viral vaccines as of November 2021 (Inventprise website, November 2021)
- 29 Nov 2021 Early research in COVID-2019 infections (Prevention) in USA (Parenteral) as of November 2021 (Inventprise pipeline, November 2021)